Molnupiravir When Used Alone Seems to Be Safe and Effective as Outpatient COVID-19 Therapy for Hemodialyzed Patients and Kidney Transplant Recipients

Background: Molnupiravir demonstrated an in vitro antiviral activity against positive-sense RNA viruses, including SARS-CoV-2. The study aimed to present the results of outpatient molnupiravir use in kidney transplant recipients and hemodialysis patients during the first months of 2022 in Poland. Me...

Descripción completa

Detalles Bibliográficos
Autores principales: Poznański, Paweł, Augustyniak-Bartosik, Hanna, Magiera-Żak, Anna, Skalec, Karolina, Jakuszko, Katarzyna, Mazanowska, Oktawia, Janczak, Dariusz, Krajewska, Magdalena, Kamińska, Dorota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610487/
https://www.ncbi.nlm.nih.gov/pubmed/36298779
http://dx.doi.org/10.3390/v14102224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610487/
https://www.ncbi.nlm.nih.gov/pubmed/36298779
http://dx.doi.org/10.3390/v14102224

Ejemplares similares